[SMC] Syndrome myasthénique congénital dû à un déficit en rapsyn: rapport de cas
Posté : 22 juin 2019 12:30
Lu sur : https://www.ncbi.nlm.nih.gov/pubmed/31226102
Traduction disponible directement en cliquant en bas à droite de ce message sur l'expression Traduire en
Medwave. 2019 Jun 4;19(5):e7645. doi: 10.5867/medwave.2019.05.7645.
Congenital myasthenic syndrome due to rapsyn deficiency: A case report with a new mutation and compound heterozygosity.
[Article in English, Spanish; Abstract available in Spanish from the publisher]
The congenital myasthenic syndromes are a heterogeneous group of genetic disorders characterized by an abnormal synaptic transmission in the neuromuscular plate.
We present a two-year-old patient, male, with hypotonia, palpebral ptosis, and proximal symmetric weakness with a neonatal onset that motivated several and prolonged hospitalizations for pneumonia and respiratory failure.
From two years of age, the parents noticed that the facial and general weakness worsened in the afternoons and with repeated or prolonged physical activity.
The physical examination showed palpebral ptosis, predominantly proximal weakness, and fatigability with sustained muscular effort.
The electromyography showed a 27% decrement in the Compound Muscular Action Potential and the case-parents genetic study showed compound heterozygosity with the transmission of two different mutations in the rapsyn gene from both parents.
The patient received pyridostigmine with great improvement, achieving optimal performance in school, sports, and daily life activities.
Weakness and fatigability with neonatal onset, mainly affecting the muscles with brain stem innervation and the decrement greater than 10 percent in the Compound Muscular Action Potential in the electromyographic studies, should make us suspect in a congenital myasthenic syndrome.
We review the literature and key clinical points to establish a timely diagnosis and effective treatment in some of these syndromes.
Article intégral NON disponible à l'achat